Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 4.785 SEK 0.74% Market Closed
Market Cap: 555.2m SEK

EV/OCF
Enterprise Value to OCF

-7.7
Current
-8
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-7.7
=
Enterprise Value
498.6m SEK
/
Operating Cash Flow
-64.7m SEK
 
SE
Ascelia Pharma AB
STO:ACE
Average EV/OCF: 20.4
Negative Multiple: -7.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 089.8
US
Abbvie Inc
NYSE:ABBV
24.2
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 474
US
Amgen Inc
NASDAQ:AMGN
17.2
US
Gilead Sciences Inc
NASDAQ:GILD
15.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -116.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.8
AU
CSL Ltd
ASX:CSL
31.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.3

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A